Patent ID: 9483612
Filing Date: 2016-11-01
CPC Classification: G01N,G16H,G16Z

Claim Text:
1. A method of determining whether a subject with elevated concentrations of very large high density lipoprotein (HDL) particles (HDL-P) is at increased risk for a cardiac event and/or CHD, comprising: providing a blood plasma or serum sample from the subject; measuring, using a NMR spectrometer; HP programmatically calculating at least one HDL interaction risk parameter associated with HDL content of the blood plasma or serum sample of the subject, the at least one HDL interaction risk parameter comprising P1 or R1, or P1 and R1, wherein P1 is a product defined by HP determining the risk for a cardiac event and/or CHD using the at least one HDL interaction risk parameter.